4.6 Article

Resistance to vincristine in DLBCL by disruption of p53-induced cell cycle arrest and apoptosis mediated by KIF18B and USP28

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma

Herve Tilly et al.

Summary: In untreated intermediate-risk or high-risk DLBCL patients, those who received pola-R-CHP had a lower risk of disease progression, relapse, or death compared to those who received R-CHOP. Overall survival and safety profiles were similar between the two groups.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Hematology

The alternative RelB NF-κB subunit is a novel critical player in diffuse large B-cell lymphoma

Baptiste Eluard et al.

Summary: RelB activation is frequently observed in DLBCL and defines a new subset of patients with distinct gene expression profile and mutational pattern. RelB positivity is associated with poor prognosis after immunochemotherapy, and it confers resistance to doxorubicin-induced apoptosis in DLBCL cells.
Review Cell Biology

Cell cycle control in cancer

Helen K. Matthews et al.

Summary: This review highlights the importance of cell cycle regulation in preventing genetic errors and cell proliferation, and how disruption of these mechanisms is associated with cancer development. Cancer arises from continuous cell division and evasion of cell cycle control mechanisms.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2022)

Article Cell Biology

An ex vivo platform to guide drug combination treatment in relapsed/refractory lymphoma

Jasmine Goh et al.

Summary: This study evaluates an experimental-analytic method, the quadratic phenotypic optimization platform (QPOP), for predicting the efficacy of patient-specific drug combinations in relapsed/refractory non-Hodgkin's lymphoma. The method shows promise in identifying effective treatments, providing a basis for further clinical trials.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Review Hematology

Upfront therapy for diffuse large B-cell lymphoma: looking beyond R-CHOP

Brian T. Hill et al.

Summary: Diffuse large B-cell lymphoma (DLBCL) is a collection of malignancies with distinct molecular features. Recent studies have identified at least five different subtypes of DLBCL, further categorizing previously recognized subtypes. Clinical trials using novel therapeutic agents to improve outcomes have been largely unsuccessful.

EXPERT REVIEW OF HEMATOLOGY (2022)

Review Biochemistry & Molecular Biology

NF-κB Mutations in Germinal Center B-Cell Lymphomas: Relation to NF-κB Function in Normal B Cells

Laura Pasqualucci et al.

Summary: Research has found that genetic mutations leading to constitutive activation of the nuclear factor-kappa B (NF-kappa B) signaling pathway exist in germinal center (GC) lymphomas. The canonical and non-canonical routes of the NF-kappa B pathway and its downstream transcription factors have distinct functions in the development of GC B cells. These findings have implications for understanding how aberrant NF-kappa B activation promotes the genesis of various GC lymphomas.

BIOMEDICINES (2022)

Article Multidisciplinary Sciences

Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition

Yael Cohen-Sharir et al.

Summary: The study shows that aneuploid cancer cells are more sensitive to genetic perturbation of SAC components and their long-term proliferation is jeopardized. Furthermore, aneuploid cells exhibit aberrant spindle geometry and dynamics, which result in mitotic defects and less-fit karyotypes over time.

NATURE (2021)

Article Cell Biology

Genome-wide CRISPR screens reveal synthetic lethal interaction between CREBBP and EP300 in diffuse large B-cell lymphoma

Man Nie et al.

Summary: The study investigated DLBCL cell line RC-K8 through whole-genome and transcriptome sequencing, identifying dependencies on CREBBP and MDM2. The dependency on CREBBP is linked to a balanced translocation involving EP300, and the synthetic lethal interaction between CREBBP and EP300 was validated. The results suggest potential therapeutic options for DLBCL cases with mutations in CREBBP or EP300.

CELL DEATH & DISEASE (2021)

Article Hematology

Deciphering the mechanisms of CC-122 resistance in DLBCL via a genome-wide CRISPR screen

Zhongying Mo et al.

Summary: The study conducted genome-wide CRISPR/Cas9 screening and mechanistic characterization of CC-122 in DLBCL cell lines, identifying genes that regulate the response to CC-122, including both known and novel genetic factors.

BLOOD ADVANCES (2021)

Article Oncology

Combined EZH2 Inhibition and IKAROS Degradation Leads to Enhanced Antitumor Activity in Diffuse Large B-cell Lymphoma

Kit Tong et al.

Summary: The study focuses on uncovering the genetic and pharmacologic opportunities to enhance the clinical efficacy of EZH2 inhibitors in DLBCL, specifically through the sensitizing effect of IKZF1 loss and combination treatment with lenalidomide. Transcriptomic and epigenetic analyses shed light on the synergistic modulation of epigenetic changes and enhancement of antitumor effects in DLBCL with the combination treatment.

CLINICAL CANCER RESEARCH (2021)

Article Cell Biology

The nuclear kinesin KIF18B promotes 53BP1-mediated DNA double-strand break repair

Janna Luessing et al.

Summary: KIF18B, a nuclear kinesin, interacts with 53BP1 and plays a crucial role in 53BP1-mediated DSB repair by enhancing the interaction between 53BP1 and histone H4. Its central motif, the Tudor-interacting motif (TIM), is essential for this function. The motor function of KIF18B is also required for efficient 53BP1 focal recruitment in response to damage and for fusion of dysfunctional telomeres, suggesting a role in 53BP1-mediated end-joining of DSBs.

CELL REPORTS (2021)

Article Computer Science, Interdisciplinary Applications

An efficient and effective method to identify significantly perturbed subnetworks in cancer

Le Yang et al.

Summary: FDRnet is a method for detecting molecular subnetworks in cancer, addressing various challenges and outperforming other methods in detecting functionally homogeneous subnetworks in scale-free biological networks. It controls FDRs of genes in detected subnetworks, improves computational efficiency, and integrates multi-omics data, facilitating the detection of key functional pathways in cancer and other genetic diseases.

NATURE COMPUTATIONAL SCIENCE (2021)

Article Biochemical Research Methods

ShinyGO: a graphical gene-set enrichment tool for animals and plants

Steven Xijin Ge et al.

BIOINFORMATICS (2020)

Review Cell Biology

mTOR at the nexus of nutrition, growth, ageing and disease

Grace Y. Liu et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)

Article Biochemistry & Molecular Biology

JACKS: joint analysis of CRISPR/Cas9 knockout screens

Felicity Allen et al.

GENOME RESEARCH (2019)

Letter Biotechnology & Applied Microbiology

CRISPResso2 provides accurate and rapid genome editing sequence analysis

Kendell Clement et al.

NATURE BIOTECHNOLOGY (2019)

Article Multidisciplinary Sciences

A multiprotein supercomplex controlling oncogenic signalling in lymphoma

James D. Phelan et al.

NATURE (2018)

Article Medicine, General & Internal

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

R. Schmitz et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Cell Biology

Targeting deubiquitinase USP28 for cancer therapy

Xiaofang Wang et al.

CELL DEATH & DISEASE (2018)

Article Multidisciplinary Sciences

Structural basis for ATP-dependent chromatin remodelling by the INO80 complex

Sebastian Eustermann et al.

NATURE (2018)

Article Multidisciplinary Sciences

The ASCIZ-DYNLL1 axis promotes 53BP1-dependent non-homologous end joining and PARP inhibitor sensitivity

Jordan R. Becker et al.

NATURE COMMUNICATIONS (2018)

Article Multidisciplinary Sciences

Structural basis of human kinesin-8 function and inhibition

Julia Locke et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Review Cell Biology

A New Mode of Mitotic Surveillance

Bramwell G. Lambrus et al.

TRENDS IN CELL BIOLOGY (2017)

Article Biochemistry & Molecular Biology

Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma

Anupama Reddy et al.

Article Hematology

Tonic B-cell receptor signaling in diffuse large B-cell lymphoma

Ondrej Havranek et al.

Article Oncology

Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas

Ryan D. Morin et al.

CLINICAL CANCER RESEARCH (2016)

Article Cell Biology

A USP28-53BP1-p53-p21 signaling axis arrests growth after centrosome loss or prolonged mitosis

Bramwell G. Lambrus et al.

JOURNAL OF CELL BIOLOGY (2016)

Article Biotechnology & Applied Microbiology

Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9

John G. Doench et al.

NATURE BIOTECHNOLOGY (2016)

Article Biotechnology & Applied Microbiology

Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR

Wei Li et al.

GENOME BIOLOGY (2015)

Review Pharmacology & Pharmacy

Targeting Multidrug Resistance Protein 1 (MRP1, ABCC1): Past, Present, and Future

Susan P. C. Cole

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54 (2014)

Article Biochemistry & Molecular Biology

Measuring error rates in genomic perturbation screens: gold standards for human functional genomics

Traver Hart et al.

MOLECULAR SYSTEMS BIOLOGY (2014)

Article Biotechnology & Applied Microbiology

Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library

Hiroko Koike-Yusa et al.

NATURE BIOTECHNOLOGY (2014)

Article Multidisciplinary Sciences

Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells

Ophir Shalem et al.

SCIENCE (2014)

Article Multidisciplinary Sciences

Genetic Screens in Human Cells Using the CRISPR-Cas9 System

Tim Wang et al.

SCIENCE (2014)

Article Cell Biology

Cytotoxicity of Paclitaxel in Breast Cancer Is due to Chromosome Missegregation on Multipolar Spindles

Lauren M. Zasadil et al.

SCIENCE TRANSLATIONAL MEDICINE (2014)

Article Biochemistry & Molecular Biology

Kinesin-12 Differentially Affects Spindle Assembly Depending on Its Microtubule Substrate

Emma G. Sturgill et al.

CURRENT BIOLOGY (2013)

Article Biochemistry & Molecular Biology

Kif18A Uses a Microtubule Binding Site in the Tail for Plus-End Localization and Spindle Length Regulation

Lesley N. Weaver et al.

CURRENT BIOLOGY (2011)

Review Oncology

A History of Cancer Chemotherapy

Vincent T. DeVita et al.

CANCER RESEARCH (2008)

Article Multidisciplinary Sciences

Structural basis for understanding oncogenic p53 mutations and designing rescue drugs

Andreas C. Joerger et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Multidisciplinary Sciences

In vivo activation of the p53 pathway by small-molecule antagonists of MDM2

LT Vassilev et al.

SCIENCE (2004)

Article Genetics & Heredity

Dynamics of the p53-Mdm2 feedback loop in individual cells

G Lahav et al.

NATURE GENETICS (2004)